Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07065864 · ClinicalTrials.gov registry record · NA

Ketone Esters for Optimization of Operator Performance in Hypoxia

A NA study of Hypoxia, sponsored by Florida Institute for Human and Machine Cognition.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT07065864 is a NA study of Hypoxia that has completed, run by Florida Institute for Human and Machine Cognition. The registered enrollment target is 17 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07065864, a NA study of Hypoxia, has completed, sponsored by Florida Institute for Human and Machine Cognition.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of the study was to investigate effects of an orally administered ketone ester drink on endurance exercise performance during acute extreme hypoxia. Drinking this ketone supplement increases energy substrates known as ketone bodies in the blood, which may also act as metabolic signaling molecules. The ketone drink used in this study is recognized by the FDA as generally regarded as safe (GRAS). Some reports suggest that high ketone levels may enhance one's ability to tolerate hypoxia.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Ketone ester

Study Locations (1)

Florida

  • Florida Institute for Human and Machine Cognition - Pensacola

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2023-08-04
Est. Completion 2023-11-14
Phase NA

What the Registry Record Tells You About NCT07065864

The ClinicalTrials.gov registry entry for NCT07065864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The listed sponsor is Florida Institute for Human and Machine Cognition, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07065864 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07065864 about?

NCT07065864 is a clinical study titled "Ketone Esters for Optimization of Operator Performance in Hypoxia". The primary purpose of the study was to investigate effects of an orally administered ketone ester drink on endurance exercise performance during acute extreme hypoxia. Drinking this ketone supplement increases energy substrates known as ketone bodies in the blood, which may also act as metabolic si...

What is the current status of trial NCT07065864?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-08-04. Estimated completion is 2023-11-14.

What conditions does trial NCT07065864 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT07065864?

The interventions under investigation include: Placebo (OTHER), Ketone ester (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07065864?

This trial is sponsored by Florida Institute for Human and Machine Cognition, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07065864 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.